NASDAQ : CERS
Cerus Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 2.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 459.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 459.48M |
| Enterprise Value | 480.01M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 201.52M |
| Shares Outstanding | 201.52M |
| Shares Change (YoY) | +3.89% |
| Shares Change (QoQ) | +3.31% |
| Owned by Insiders (%) | 3.06% |
| Owned by Institutions (%) | 72.72% |
| Float | 195.35M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| Forward PS | 1.77 |
| PB Ratio | 6.56 |
| P/TBV Ratio | 6.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 190.10 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.17 |
| EV / EBITDA | 7,272.91 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.83 |
| Quick Ratio | 1.02 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | 17.92 |
| Debt / FCF | n/a |
| Interest Coverage | -0.21 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -10.77% |
| Return on Assets (ROA) | -0.48% |
| Return on Invested Capital (ROIC) | -0.67% |
| Return on Capital Employed (ROCE) | -1.35% |
| Weighted Average Cost of Capital (WACC) | 13.39% |
| Revenue Per Employee | $805,640 |
| Profits Per Employee | -$24,665 |
| Employee Count | 275 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.77 |
Taxes
| Measure | Value |
|---|
| Income Tax | 390,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +57.24% |
| 50-Day Moving Average | 2.47 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 43.04 |
| Average Volume (20 Days) | 1,801,498 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 16.63M |
| Short Previous Month | 17.58M |
| Short % of Shares Out | 8.25% |
| Short % of Float | 8.51% |
| Short Ratio (days to cover) | 8.47 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 221.55M |
| Gross Profit | 115.32M |
| Operating Income | -1.62M |
| Pretax Income | -6.44M |
| Net Income | -6.78M |
| EBITDA | 66,000 |
| EBIT | -1.62M |
| Loss Per Share | -$0.03 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 56.26M |
| Total Debt | 76.80M |
| Net Cash | -20.54M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 70.72M |
| Book Value Per Share | 0.35 |
| Working Capital | 71.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.42M |
| Capital Expenditures | -4.25M |
| Depreciation & Amortization | 1.68M |
| Net Borrowing | -19.91M |
| Free Cash Flow | -1.83M |
| FCF Per Share | -$0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 52.05% |
| Operating Margin | -0.73% |
| Pretax Margin | -2.91% |
| Profit Margin | -3.06% |
| EBITDA Margin | 0.03% |
| EBIT Margin | -0.73% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.89% |
| Shareholder Yield | -3.89% |
| Earnings Yield | -1.53% |
| FCF Yield | -0.40% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.13 |
| Price Target Difference | 125.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 12.69% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.28 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |